Your browser doesn't support javascript.
loading
Phase II trial of daily S-1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101.
Kawashima, Yosuke; Ishimoto, Osamu; Miyauchi, Eisaku; Sakakibara, Tomohiro; Harada, Toshiyuki; Usui, Kazuhiro; Inoue, Akira; Sugawara, Shunichi.
Afiliação
  • Kawashima Y; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan.
  • Ishimoto O; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan.
  • Miyauchi E; Okino Medical Clinic, Sendai, Japan.
  • Sakakibara T; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Harada T; Department of Respiratory Medicine, Tohoku Rosai Hospital, Sendai, Japan.
  • Usui K; Department of Respiratory Medicine, JCHO Hokkaido Hospital, Sapporo, Japan.
  • Inoue A; Division of Respirology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Sugawara S; Department of Palliative Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Thorac Cancer ; 14(27): 2804-2810, 2023 09.
Article em En | MEDLINE | ID: mdl-37589158
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article